Ayako Chida-Nagai Takao Tsujioka Daisuke Sasaki Gaku Izumi Hirokuni Yamazawa Atsuhito Takeda
10.3389/fped.2022.909595
Front Pediatr
2022 Jun 17;10:909595.
adolescence drug transition epoprostenol pulmonary arterial hypertension selexipag
CC BY
https://pubmed.ncbi.nlm.nih.gov/35783314/
Case Reports
PMC9247454
35783314
An Adolescent Patient With Idiopathic Pulmonary Arterial Hypertension Weaned Off Intravenous Epoprostenol Following Treatment With Selexipag: A Case Report
2022